Syneos Health Inc. (NASDAQ:SYNH) changes shares on Monday trading session, with a change of -1.14% or -$0.63 shares. The trading starts at $54.64 and closed at $55.30 throughout the day. The trading session low price was $53.59 and day high was $55.45 on Monday, June 22. After the session, the Healthcare sector daily volume shifted to 0.61 million while its average volume is 648.10K. In other hand, the SYNH market cap reached to $5.57B. While, its current target price is $54.67 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 1.86% and down -8.19% for month. Its quarterly performance was 61.65% above, while its half year performance is down -5.02%. SYNH yearly performance stood at positive 10.36% and fall -8.08% for year-to-date. Current recommendation for Syneos Health Inc. is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. SYNH EPS (TTM) for 12-month is 1.85. EPS for this year is 467.60%, while for the next year its value is 3.71. Sales growth for the current quarter is 2.97 while its EPS Q/Q reached 209.50%. It has an EPS of 34.80% up for past five years and for the next five years will be up 9.96%.
Let’s take a look on the analyst recommendations on SYNH for the current month and previous month. For the current month, 8 of 14 analysts recommend stock as Buy while 0 as Sell, 1 as overweight, 0 as underweight and 5 as Hold. As compared with the previous month ratings, 14 analysts participate in stock recommendation. Out of 14, 0 rated it sell, 8 rated it as Buy and 4 as Hold Ratings. On the other hand, target price ranges from $50.00-$77.00. Average target price for SYNH was reached at $65.50.
The insider ownership moved to 0.50%.
The company posted an EPS (TTM) of 1.85. According to the most recent quarter report on (Jun 2020), 12 analysts estimated an average EPS of 0.46, while 0.74 EPS posted a year ago period. Analyst Estimated EPS for SYNH published in the report was 0.31-0.53 during the same period. Comparing with last year, the average estimated EPS was 0.74 which is higher than 0.68 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for SYNH fall -0.89% for period of 200 days. SMA for 50 days was -0.94% which is showing red signal, while SMA-20 was -5.82%. The moving average value for Syneos Health Inc. (SYNH) is 56.24 and 57.14 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in SYNH stock. On May 20, KEEFE MICHELLE, Pres., Commercial Solutions, sold 2,500 trading shares at the cost of $60.00, which valued at 0.15 million. On Apr 20, Parks Robert, EVP, Chief Accounting Officer, sold 3,588 shares at the cost of $49.65, with total shares of 12,450. On Mar 20, Meggs Jason M., Chief Financial Officer, bought 3,555 shares at the cost of 36.74. After this transaction, Meggs Jason M. total shares reached to 63,829 which valued at 0.13 million.